{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:02:29Z","timestamp":1793088149731,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaut.2023.103122","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T12:33:29Z","timestamp":1697718809000},"page":"103122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Genetic predisposition to sarcoidosis"],"prefix":"10.1016","volume":"149","author":[{"given":"Shu-Yi","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasha","family":"Fingerlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2023.103122_bib1","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/joim.13629","article-title":"Sarcoidosis: epidemiology and clinical insights","volume":"293","author":"Rossides","year":"2023","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2023.103122_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1098-2272(1996)13:1<23::AID-GEPI3>3.0.CO;2-7","article-title":"Heterogeneity of familial risk in sarcoidosis","volume":"13","author":"Rybicki","year":"1996","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.jaut.2023.103122_bib3","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1164\/ajrccm.164.11.2106001","article-title":"Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS)","volume":"164","author":"Rybicki","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1086\/378097","article-title":"HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites","volume":"73","author":"Rossman","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jaut.2023.103122_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-0039.2007.00879.x","article-title":"Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis","volume":"70","author":"Spagnolo","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2023.103122_bib6","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/hmg\/ddq325","article-title":"Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups","volume":"19","author":"Sato","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jaut.2023.103122_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humimm.2011.10.016","article-title":"HLA-DRB1 allele frequencies and C4 copy number variation in Finnish sarcoidosis patients and associations with disease prognosis","volume":"73","author":"Wennerstrom","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib8","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.1038\/s41598-022-13199-w","article-title":"HLA class II variants defined by next generation sequencing are associated with sarcoidosis in Korean patients","volume":"12","author":"Sikorova","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2023.103122_bib9","doi-asserted-by":"crossref","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","article-title":"Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations","volume":"39","author":"Gonzalez-Galarza","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jaut.2023.103122_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1094843","article-title":"Association between sarcoidosis and HLA polymorphisms in a Czech population from Central Europe: focus on a relationship with clinical outcome and treatment","volume":"10","author":"Sikorova","year":"2023","journal-title":"Front. Med."},{"issue":"16","key":"10.1016\/j.jaut.2023.103122_bib11","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1093\/hmg\/ddad067","article-title":"Genome-wide association study identifies multiple HLA loci for sarcoidosis susceptibility","volume":"32","author":"Liao","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jaut.2023.103122_bib12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1519","article-title":"Sarcoidosis is associated with a truncating splice site mutation in BTNL2","volume":"37","author":"Valentonyte","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2023.103122_bib13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1164\/ajrccm.164.5.2007056","article-title":"Results from a genome-wide search for predisposing genes in sarcoidosis","volume":"164","author":"Schurmann","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/thx.2005.056564","article-title":"BTNL2 gene variant and sarcoidosis","volume":"61","author":"Li","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.jaut.2023.103122_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13023-016-0546-4","article-title":"Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort","volume":"11","author":"Pacheco","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jaut.2023.103122_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.humimm.2011.01.011","article-title":"Butyrophilin-like 2 in pulmonary sarcoidosis: a factor for susceptibility and progression?","volume":"72","author":"Wijnen","year":"2011","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib17","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1167\/iovs.12-10491","article-title":"Genetic characterization and susceptibility for sarcoidosis in Japanese patients: risk factors of BTNL2 gene polymorphisms and HLA class II alleles","volume":"53","author":"Suzuki","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jaut.2023.103122_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.meegid.2010.02.006","article-title":"Analysis of the association between BTNL2 polymorphism and tuberculosis in Chinese Han population","volume":"10","author":"Lian","year":"2010","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.jaut.2023.103122_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1086\/444435","article-title":"The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites","volume":"77","author":"Rybicki","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jaut.2023.103122_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1164\/ajrccm.165.8.200110-0320","article-title":"Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis","volume":"165","author":"Grutters","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3109\/14397595.2015.1008778","article-title":"TNF-308 G\/A polymorphism and risk of systemic lupus erythematosus in the Polish population","volume":"25","author":"Piotrowski","year":"2015","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2023.103122_bib22","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/ajrccm.156.5.97-02050","article-title":"Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers","volume":"156","author":"Ziegenhagen","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2249.2007.03564.x","article-title":"Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians","volume":"151","author":"Sharma","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib24","first-page":"131","article-title":"TNF-alpha and TNF-beta gene polymorphisms in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis","volume":"27","author":"Kieszko","year":"2010","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2023.103122_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11033-013-2859-x","article-title":"Associations between TNF-alpha -308 A\/G and lymphotoxin-alpha +252 A\/G polymorphisms and susceptibility to sarcoidosis: a meta-analysis","volume":"41","author":"Song","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jaut.2023.103122_bib26","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1183\/09031936.00169413","article-title":"Association of the TNF-alpha G-308A polymorphism with TNF-inhibitor response in sarcoidosis","volume":"43","author":"Wijnen","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103122_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01124-2017","article-title":"Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes","volume":"51","author":"Broos","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103122_bib28","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-gamma-Producing T-helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-helper type 1 cells","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/2011\/185106","article-title":"Association of interleukin 23 receptor gene with sarcoidosis","volume":"31","author":"Kim","year":"2011","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jaut.2023.103122_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/rccm.201503-0418OC","article-title":"Identification of immune-relevant factors conferring sarcoidosis genetic risk","volume":"192","author":"Fischer","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s42003-020-01185-9","article-title":"Genetic control of CCL24, POR, and IL23R contributes to the pathogenesis of sarcoidosis","volume":"3","author":"Meguro","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jaut.2023.103122_bib32","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2011.06.017","article-title":"Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway","volume":"66","author":"Judson","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2023.103122_bib33","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103122_bib34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1165\/ajrcmb.22.6.3745","article-title":"The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis","volume":"22","author":"Maliarik","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jaut.2023.103122_bib35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJM199803053381002","article-title":"Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans","volume":"338","author":"Bellamy","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2023.103122_bib36","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1574-695X.2007.00231.x","article-title":"The human solute carrier family 11 member 1 protein (SLC11A1): linking infections, autoimmunity and cancer?","volume":"49","author":"Awomoyi","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.jaut.2023.103122_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jmg.36.4.295","article-title":"Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility","volume":"36","author":"Searle","year":"1999","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.jaut.2023.103122_bib38","first-page":"153","article-title":"The functional polymorphisms of NRAMP1 gene in Greeks with sarcoidosis","volume":"24","author":"Gazouli","year":"2007","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2023.103122_bib39","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.ejhg.5201370","article-title":"Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland","volume":"13","author":"Dubaniewicz","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.jaut.2023.103122_bib40","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1007\/s11033-011-1297-x","article-title":"The functional SLC11A1 gene polymorphisms are associated with sarcoidosis in Turkish population","volume":"39","author":"Akcakaya","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jaut.2023.103122_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12967-016-0843-7","article-title":"Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosis","volume":"14","author":"Mirsaeidi","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jaut.2023.103122_bib42","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ng.198","article-title":"Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis","volume":"40","author":"Hofmann","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2023.103122_bib43","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/17476348.2020.1784729","article-title":"Association of TGF-beta3 and ANXA11 with pulmonary sarcoidosis in Greek population","volume":"14","author":"Sikorova","year":"2020","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.jaut.2023.103122_bib44","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/gene.2011.27","article-title":"Functional variant ANXA11 R230C: true marker of protection and candidate disease modifier in sarcoidosis","volume":"12","author":"Mrazek","year":"2011","journal-title":"Gene Immun."},{"key":"10.1016\/j.jaut.2023.103122_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/gene.2012.48","article-title":"Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans","volume":"14","author":"Levin","year":"2013","journal-title":"Gene Immun."},{"key":"10.1016\/j.jaut.2023.103122_bib46","first-page":"102","article-title":"The association between ANXA11 gene polymorphisms and sarcoidosis: a meta-analysis and systematic review","volume":"33","author":"Zhou","year":"2016","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2023.103122_bib47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.cellbio.21.122303.115827","article-title":"Recognition and signaling by toll-like receptors","volume":"22","author":"West","year":"2006","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.jaut.2023.103122_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1399-0039.2011.01808.x","article-title":"Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis","volume":"79","author":"Veltkamp","year":"2012","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2023.103122_bib49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2249.2010.04205.x","article-title":"Toll-like receptor (TLR)-9 genetics and function in sarcoidosis","volume":"162","author":"Veltkamp","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib50","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2249.2007.03428.x","article-title":"Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis","volume":"149","author":"Veltkamp","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2249.2006.03127.x","article-title":"Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients","volume":"145","author":"Veltkamp","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib52","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.21037\/atm-20-6103","article-title":"Toll-like receptors 2 expression in mediastinal lymph node of patients with sarcoidosis","volume":"8","author":"Chen","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jaut.2023.103122_bib53","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1165\/rcmb.2015-0278OC","article-title":"Functional toll-like receptor 9 expression and CXCR3 ligand release in pulmonary sarcoidosis","volume":"55","author":"Schnerch","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jaut.2023.103122_bib54","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00033812","article-title":"Genome-wide association analysis reveals 12q13.3-q14.1 as new risk locus for sarcoidosis","volume":"41","author":"Hofmann","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103122_bib55","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1164\/rccm.201204-0708OC","article-title":"A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1","volume":"186","author":"Fischer","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib56","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1183\/09031936.00001711","article-title":"A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1","volume":"38","author":"Hofmann","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103122_bib57","first-page":"672","article-title":"Association of BAFF and BAFF-R polymorphisms with sarcoidosis in a Greek patient cohort","volume":"19","author":"Martinou","year":"2023","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.jaut.2023.103122_bib58","article-title":"Novel human FCGR1A variants affect CD64 functions and are risk factors for sarcoidosis","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12920-018-0338-x","article-title":"Whole exome sequencing in three families segregating a pediatric case of sarcoidosis","volume":"11","author":"Calender","year":"2018","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.jaut.2023.103122_bib60","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1007\/s10067-021-05684-w","article-title":"Whole genome sequencing identifies variants associated with sarcoidosis in a family with a high prevalence of sarcoidosis","volume":"40","author":"Fritz","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2023.103122_bib61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1566523223666230119143501","article-title":"Whole exome sequencing identified two single nucleotide polymorphisms of human leukocyte antigen-DRB5 in familial sarcoidosis in China","volume":"23","author":"Zhang","year":"2023","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.jaut.2023.103122_bib62","article-title":"Exome sequencing reveals genetic variability and identifies chronic prognostic loci in Chinese sarcoidosis patients","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jaut.2023.103122_bib63","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis statement committee. American thoracic society. European respiratory society. World association for sarcoidosis and other granulomatous disorders","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103122_bib64","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2796.2008.01984.x","article-title":"A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Lofgren's syndrome","volume":"264","author":"Spagnolo","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2023.103122_bib65","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1465-9921-11-25","article-title":"Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients","volume":"11","author":"Grunewald","year":"2010","journal-title":"Respir. Res."},{"key":"10.1016\/j.jaut.2023.103122_bib66","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1165\/rcmb.4782","article-title":"HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis","volume":"27","author":"Sato","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jaut.2023.103122_bib67","first-page":"96","article-title":"Major histocompatibility complex class II transactivator gene polymorphism: associations with Lofgren's syndrome","volume":"76","author":"Grunewald","year":"2010","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2023.103122_bib68","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1164\/rccm.200303-456OC","article-title":"C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome","volume":"168","author":"Spagnolo","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib69","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-0039.2005.00370.x","article-title":"Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis","volume":"65","author":"Mrazek","year":"2005","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2023.103122_bib70","first-page":"11","article-title":"ANXA11 rs1049550 associates with lofgren's syndrome and chronic sarcoidosis patients","author":"Karakaya","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jaut.2023.103122_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081967","article-title":"A polymorphism in C-C chemokine receptor 5 (CCR5) associates with lofgren's syndrome and alters receptor expression as well as functional response","volume":"10","author":"Karakaya","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaut.2023.103122_bib72","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ni1191","article-title":"T cell costimulation by chemokine receptors","volume":"6","author":"Molon","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib73","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"Baughman","year":"2011","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2023.103122_bib74","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2249.2006.03008.x","article-title":"Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis","volume":"143","author":"Pabst","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib75","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1183\/09031936.00049410","article-title":"Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes","volume":"37","author":"Fischer","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103122_bib76","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.3389\/fimmu.2019.02964","article-title":"Exome sequencing identifies susceptibility loci for sarcoidosis prognosis","volume":"10","author":"Lahtela","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib77","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation","volume":"2","author":"Scadding","year":"1961","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jaut.2023.103122_bib78","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1164\/rccm.200209-1097OC","article-title":"Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans","volume":"167","author":"Iannuzzi","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib79","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.humimm.2005.04.003","article-title":"Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602-DRB1*150101","volume":"66","author":"Voorter","year":"2005","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib80","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12931-020-01537-3","article-title":"Differential transcriptomics in sarcoidosis lung and lymph node granulomas with comparisons to pathogen-specific granulomas","volume":"21","author":"Casanova","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.jaut.2023.103122_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.822094","article-title":"Transcriptome analysis of peripheral blood mononuclear cells in pulmonary sarcoidosis","volume":"9","author":"Yoshioka","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2023.103122_bib82","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MCP.0000000000000301","article-title":"From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis","volume":"22","author":"Bonham","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.jaut.2023.103122_bib83","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103122_bib84","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.537382","article-title":"Sarcoidosis epidemiology: race matters","volume":"11","author":"Hena","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib86","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1164\/rccm.200512-1839OC","article-title":"Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis","volume":"174","author":"Hill","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib87","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1378\/chest.129.6.1584","article-title":"Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis","volume":"129","author":"Kruit","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2023.103122_bib88","article-title":"Inclusivity in Research Matters: Variants in PVT1 Specific to People of African Descent Are Associated with Pulmonary Fibrosis","author":"Garman","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaut.2023.103122_bib89","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-beta in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2023.103122_bib90","first-page":"129","article-title":"Association of HLA DQB1 0602 in sarcoidosis patients with small fiber neuropathy","volume":"22","author":"Voorter","year":"2005","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2023.103122_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577849","article-title":"Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis","volume":"367","author":"Byg","year":"2022","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2023.103122_bib92","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/acn3.229","article-title":"Fine mapping of chromosome 15q25 implicates ZNF592 in neurosarcoidosis patients","volume":"2","author":"Lareau","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jaut.2023.103122_bib93","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1034\/j.1399-0039.2000.560107.x","article-title":"HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis","volume":"56","author":"Naruse","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2023.103122_bib94","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijcard.2022.04.006","article-title":"Phenotypic and HLA-DRB1 allele characterization of Swedish cardiac sarcoidosis patients","volume":"359","author":"Eldhagen","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jaut.2023.103122_bib95","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1007\/s10067-018-4183-2","article-title":"Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis","volume":"37","author":"Ando","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2023.103122_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043588","article-title":"Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels","volume":"7","author":"Saussine","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2023.103122_bib97","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccm.2015.08.009","article-title":"Ocular sarcoidosis","volume":"36","author":"Pasadhika","year":"2015","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.jaut.2023.103122_bib98","first-page":"59","article-title":"Association of genetic variants in RAB23 and ANXA11 with uveitis in sarcoidosis","volume":"24","author":"Davoudi","year":"2018","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jaut.2023.103122_bib99","first-page":"1690","article-title":"BTNL2 gene polymorphism and sarcoid uveitis","volume":"103","author":"Chaperon","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jaut.2023.103122_bib100","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/09273948.2019.1705985","article-title":"Genome-wide association study of ocular sarcoidosis confirms HLA associations and implicates barrier function and autoimmunity in African Americans","volume":"29","author":"Garman","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.jaut.2023.103122_bib101","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/09273948.2020.1861306","article-title":"Peripheral blood transcriptome in patients with sarcoidosis-associated uveitis","volume":"30","author":"Gonzales","year":"2022","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.jaut.2023.103122_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106537","article-title":"HLA-DRB1 alleles associate with hypercalcemia in sarcoidosis","volume":"187","author":"Werner","year":"2021","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2023.103122_bib103","first-page":"711","article-title":"Sarcoid arthropathy and the association with the human leukocyte antigen. The Icelandic Sarcoidosis Study","volume":"31","author":"Petursdottir","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2023.103122_bib104","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/ard.61.6.499","article-title":"Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors","volume":"61","author":"Visser","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103122_bib105","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1165\/rcmb.2014-0227OC","article-title":"Association of HLA-DRB1 with sarcoidosis susceptibility and progression in African Americans","volume":"53","author":"Levin","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jaut.2023.103122_bib106","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.humimm.2011.03.020","article-title":"Human leukocyte antigen-A, -B, and -DRB1 alleles and sarcoidosis in Chinese Han subjects","volume":"72","author":"Zhou","year":"2011","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043907","article-title":"Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility","volume":"7","author":"Adrianto","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2023.103122_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092646","article-title":"Admixture fine-mapping in African Americans implicates XAF1 as a possible sarcoidosis risk gene","volume":"9","author":"Levin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2023.103122_bib109","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/jid.2008.456","article-title":"Variation in the lymphotoxin-alpha\/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis","volume":"129","author":"McDougal","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jaut.2023.103122_bib110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1183\/09031936.04.00005904","article-title":"Sarcoidosis and granuloma genes: a family-based study in African-Americans","volume":"24","author":"Rybicki","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103122_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1132799","article-title":"Sex differences in the genetics of sarcoidosis across European and African ancestry populations","volume":"10","author":"Xiong","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2023.103122_bib112","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.021532018","article-title":"Moving target: shifting the focus to pulmonary sarcoidosis as an autoimmune spectrum disorder","volume":"54","author":"Kaiser","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103122_bib113","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/gene.2017.3","article-title":"Polygenic risk assessment reveals pleiotropy between sarcoidosis and inflammatory disorders in the context of genetic ancestry","volume":"18","author":"Lareau","year":"2017","journal-title":"Gene Immun."},{"key":"10.1016\/j.jaut.2023.103122_bib114","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1093\/rheumatology\/keaa232","article-title":"The genetics of rheumatoid arthritis","volume":"59","author":"Dedmon","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2023.103122_bib115","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.3389\/fimmu.2019.02933","article-title":"Sarcoidosis as an autoimmune disease","volume":"10","author":"Starshinova","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib116","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1183\/09031936.00150609","article-title":"Chronic interstitial pneumonitis in end-stage sarcoidosis","volume":"35","author":"Shigemitsu","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2023.103122_bib117","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.chest.2020.03.037","article-title":"Diagnostic and prognostic biomarkers for chronic fibrosing interstitial lung diseases with a progressive phenotype","volume":"158","author":"Inoue","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2023.103122_bib118","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.trsl.2012.03.005","article-title":"The clinical and immunologic features of pulmonary fibrosis in sarcoidosis","volume":"160","author":"Patterson","year":"2012","journal-title":"Transl. Res."},{"key":"10.1016\/j.jaut.2023.103122_bib119","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12863-016-0377-2","article-title":"Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia","volume":"17","author":"Fingerlin","year":"2016","journal-title":"BMC Genet."},{"key":"10.1016\/j.jaut.2023.103122_bib120","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1164\/rccm.200303-459OC","article-title":"Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients","volume":"169","author":"Grunewald","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib121","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1164\/ajrccm.156.5.9704069","article-title":"HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis","volume":"156","author":"Berlin","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib122","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1513\/pats.201203-023AW","article-title":"The impact of TGF-beta on lung fibrosis: from targeting to biomarkers","volume":"9","author":"Fernandez","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.jaut.2023.103122_bib123","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/rheumatology\/ker316","article-title":"Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis","volume":"51","author":"Ten Berge","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2023.103122_bib124","doi-asserted-by":"crossref","first-page":"L487","DOI":"10.1152\/ajplung.00301.2018","article-title":"Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A\/IL-17RA in human fibrotic interstitial lung disease","volume":"316","author":"Zhang","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.jaut.2023.103122_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071059","article-title":"Meta-analysis of genetic programs between idiopathic pulmonary fibrosis and sarcoidosis","volume":"8","author":"Leng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2023.103122_bib126","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2249.2010.04181.x","article-title":"MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases","volume":"161","author":"Korthagen","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib127","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/cei.12139","article-title":"S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1\/2, mitogen-activated protein-kinase and nuclear factor-kappaB-dependent pathways","volume":"173","author":"Xu","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2023.103122_bib128","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2023.103122_bib129","first-page":"125","article-title":"HLA and environmental interactions in sarcoidosis","volume":"25","author":"Rossman","year":"2008","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2023.103122_bib130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.rmed.2016.10.003","article-title":"Obesity and risk of sarcoidosis: a population-based nested case-control study","volume":"120","author":"Ungprasert","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2023.103122_bib131","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54612-1","article-title":"A gene-environment interaction between smoking and gene polymorphisms provides a high risk of two subgroups of sarcoidosis","volume":"9","author":"Rivera","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2023.103122_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16101830","article-title":"Genetic variants associated with FDNY WTC-related sarcoidosis","volume":"16","author":"Cleven","year":"2019","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.jaut.2023.103122_bib133","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41591-021-01672-4","article-title":"A roadmap to increase diversity in genomic studies","volume":"28","author":"Fatumo","year":"2022","journal-title":"Nat. Med."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123001312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123001312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T11:39:56Z","timestamp":1738496396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841123001312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":133,"alternative-id":["S0896841123001312"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103122","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic predisposition to sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103122"}}